<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:contributor>Nicola Pussini</dc:contributor>
  <dc:contributor>Susan Smith</dc:contributor>
  <dc:contributor>Judy L. Williamson</dc:contributor>
  <dc:contributor>Bradford Powell</dc:contributor>
  <dc:contributor>Jorge E. Osorio</dc:contributor>
  <dc:creator>Tonie E. Rocke</dc:creator>
  <dc:date>2010</dc:date>
  <dc:description>&lt;p&gt;&lt;span&gt;Baits containing recombinant raccoon poxvirus (RCN) expressing plague antigens (fraction 1 [F1] and a truncated form of the V protein-V307) were offered for voluntary consumption several times over the course of several months to a group of 16 black-tailed prairie dogs (&lt;/span&gt;&lt;i&gt;Cynomys ludovicianus&lt;/i&gt;&lt;span&gt;). For comparison, another group of prairie dogs (&lt;/span&gt;&lt;i&gt;n&lt;/i&gt;&lt;span&gt; = 12) was injected subcutaneously (SC) (prime and boost) with 40 μg of F1-V fusion protein absorbed to alum, a vaccine-adjuvant combination demonstrated to elicit immunity to plague in mice and other mammals. Control animals received baits containing RCN without the inserted antigen (&lt;/span&gt;&lt;i&gt;n&lt;/i&gt;&lt;span&gt; = 8) or injected diluent (&lt;/span&gt;&lt;i&gt;n&lt;/i&gt;&lt;span&gt; = 7), and as there was no difference in their survival rates by Kaplan–Meier analysis, all of them were combined into one group in the final analysis. Mean antibody titers to&amp;nbsp;&lt;/span&gt;&lt;i&gt;Yersinia pestis&lt;/i&gt;&lt;span&gt;&amp;nbsp;F1 and V antigen increased (&lt;/span&gt;&lt;i&gt;p&lt;/i&gt;&lt;span&gt; &amp;lt; 0.05) in the vaccinated groups compared to controls, but titers were significantly higher (&lt;/span&gt;&lt;i&gt;p&lt;/i&gt;&lt;span&gt; &amp;lt; 0.0001) in those receiving injections of F1-V fusion protein than in those orally vaccinated with RCN-based vaccine. Interestingly, upon challenge with approximately 70,000 cfu of virulent&amp;nbsp;&lt;/span&gt;&lt;i&gt;Y. pestis&lt;/i&gt;&lt;span&gt;, oral vaccination resulted in survival rates that were significantly higher (&lt;/span&gt;&lt;i&gt;p&lt;/i&gt;&lt;span&gt; = 0.025) than the group vaccinated by injection with F1-V fusion protein and substantially higher (&lt;/span&gt;&lt;i&gt;p&lt;/i&gt;&lt;span&gt; &amp;lt; 0.0001) than the control group. These results demonstrate that oral vaccination of prairie dogs using RCN-based plague vaccines provides significant protection against challenge at dosages that simulate simultaneous delivery of the plague bacterium by numerous flea bites.&lt;/span&gt;&lt;/p&gt;</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>10.1089/vbz.2009.0050</dc:identifier>
  <dc:language>en</dc:language>
  <dc:publisher>Mary Ann Liebert, Inc.</dc:publisher>
  <dc:title>Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus)</dc:title>
  <dc:type>article</dc:type>
</oai_dc:dc>